A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZeneca’s Tagrisso (osimertinib), as monotherapy and as the backbone for novel ...

The Centers for Disease Control and Prevention is reportedly rescinding $11.4 billion in funds to states, cities and ...

Colorado regulators are issuing licenses for providing psychedelic mushrooms and are planning to authorize the state’s first “healing centers.

In 2023, insurers selling plans on the marketplaces created under the Affordable Care Act denied a combined average of 20% of ...

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug ...

BATTLEBORO, N.C. (WNCN) — A nearly year-long drug investigation in Edgecombe County ended with a man’s arrest Wednesday, ...

"The rapid rise and geographic spread of cases is concerning and emphasizes the need for continued surveillance, expanded lab ...

A discredited anti-vaccine advocate who has no medical background and who has been disciplined for practicing medicine ...